CASP3 and Miyoshi myopathy: In addition, we performed flow cytometry to assess the percentage of MM cells with activated caspase-3 induced by bortezomib (Fig. 5b), and the results indicated that knocking down MCPIP1 hindered the Mφs-mediated protection of MM cells from bortezomib-induced apoptosis.